郭家耀: 外圍回落港股考驗28,800支持 健倍苗苗(02161.HK)前景樂觀
正榮金融業務部副總裁郭家耀稱,美股周三(27日)急挫,企業業績未如理想,加上疫情對經濟帶來不明朗因素,投資者紛紛獲利回吐,三大指數均錄得顯著跌幅收市。聯儲局議息結果公布,維持利率及買債計劃不變,主席鮑威爾表示疫情對經濟仍構成重大下行風險,暗示息口短期難以調升,但言論未有對市況帶來太大幫助。美元表現向好,美國十年期債息回落至1.01厘水平,金價及油價走勢向下。港股預託證券普遍下跌,預料大市早段跟隨外圍大幅低開。
內地股市先跌後回升,滬綜指走勢反覆靠穩,收市上升0.2%,滬深兩市成交額略為縮減。
港股表現回落,主要受外圍走勢拖累,加上投資者趁高獲利回吐,大市在30,000點水平暫遇阻力。美股調整勢頭顯現,港股亦借勢出現回吐,考驗28,800點支持,上方阻力在30,000點水平。
另由雅各臣(02633.HK)分拆的健倍苗苗(02161.HK)公開招股,計劃發售4,468.6萬股,招股價為1.2元。公司主要業務為醫療保健品推廣及分銷,產品遍及大中華、東南亞及其他國家。公司的產品組合包括消費者醫療保健品,包括品牌藥及健康保健品;及品牌中藥,包括非處方品牌中藥及濃縮中藥顆粒產品。截至2020年底,公司經營194個品牌,包涵逾1,700款產品,當中46個為第三方品牌,148個為自主品牌。
旗下品牌中藥包括保濟丸、飛鷹活絡油、唐大宗活絡油,以及自主品牌海天牌的濃縮中藥顆粒產品。公司計劃進一步擴張產品組合,特別於醫療保健品方面,對準女性保健及育兒領域的藥妝及保健產品,以及家用式診斷產品。公司亦積極發展跨境電子商務,透過多個流行平台擴大業務,以捕捉市場機遇,發展前景樂觀。
(筆者為證監會持牌人,沒持有上述股份)~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.